Fig. 7From: Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinomaAssessment of immunotherapy response in LIHC. A. Correlations of SYNGR2 Expression with HLA gene family. B. Correlation of SYNGR2 Expression with immune checkpoint genes. C, D. Correlation between SYNGR2 and chemokines in tumors. *p < 0.05, **p < 0.01, and ***p < 0.001Back to article page